Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1194-1198

  Murakami, Tomotoshi ^a   Kanchiku, Tsukasa ^a   Suzuki, Hidenori ^a   Imajo, Yasuaki ^a   Yoshida, Yuichiro ^a   Nomura, Hiroshi ^b   Cui, Dan ^a   Ishikawa, Toshizo ^a   Ikeda, Eiji ^a   Taguchi, Toshihiko ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Allodynia; Hyperalgesia; Inflammation; Interleukin 6; Spinal cord injury

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM FUNCTION; NEUROPATHIC PAIN; NONHUMAN; SPINAL CORD INJURY; TACTILE STIMULATION;

EID: 84884787867     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1296     Document Type: Article

References (26)

1. Donnelly DJ and Popovich PG: Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209: 378-388, 2008.
2. Jones TB, McDaniel EE. and Popovich PG: Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11: 1223-1236, 2005.
3. Popovich PG and Jones TB: Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci 24: 13-17, 2003.
4. Schwab JM, Brechtel K, Mueller CA, et al: Experimental strategies to promote spinal cord regeneration an integrative perspective. Prog Neurobiol 78: 91-116, 2006.
5. Thuret S, Moon LD and Gage FH: Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 7: 628-643, 2006.
6. Lee HL, Lee KM, Son SJ, Hwang SH and Cho HJ: Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15: 2807-2811, 2004.
7. Siddall P, Xu CL and Cousins M: Allodynia following traumatic spinal cord injury in the rat. Neuroreport 6: 1241-1244, 1995
8. Okada S, Nakamura M, Mikami Y, et al: Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 76: 265-276, 2004.
9. Mukaino M, Nakamura M, Yamada O, et al: Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 224: 403-414, 2010.
10. Lacroix S, Chang L, Rose-John S and Tuszynski MH: Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol 454: 213-228, 2002.
11. Hirano T, Nakajima K and Hibi M: Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 8: 241-252, 1997.
12. Cattaneo E, Conti L and De-Fraja C: Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 22: 365-369, 1999.
13. Dominguez E, Rivat C, Pommier B, Mauborgne A and Pohl M: JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem 107: 50-60, 2008.
14. Yamauchi K, Osuka K, Takayasu M, et al: Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem 96: 1060-1070, 2006.
15. Dominguez E, Mauborgne A, Mallet J, Desclaux M and Pohl M: SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci 30: 5754-5766, 2010.
16. Okazaki M, Yamada Y, Nishimoto N, Yoshizaki K and Mihara M: Characterization of anti-mouse interleukin-6 receptor antibody. Immunol Lett 84: 231-240, 2002.
17. Scheff SW, Rabchevsky AG, Fugaccia I, Main JA and Lumpp JE Jr: Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma 20: 179-193, 2003.
18. Nakajima Y, Osuka K, Seki Y, et al: Taurine reduces inflammatory responses after spinal cord injury. J Neurotrauma 27: 403-410, 2010.
19. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM and Popovich PG: Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659, 2006.
20. Hargreaves K, Dubner R, Brown F, Flores C and Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
21. Kim HY, Wang J, Lu Y, Chung JM and Chung K: Superoxide signaling in pain is independent of nitric oxide signaling. Neuroreport 20: 1424-1428, 2009.
22. Chen KB, Uchida K, Nakajima H, et al: Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976) 36: 1350-1358, 2011.
23. Cho N, Nguyen DH, Satkunendrarajah K, Branch DR and Fehlings MG: Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury. J Neuroinflammation 9: 134, 2012.
24. Klusman I and Schwab ME: Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 762: 173-184, 1997.
25. Guerrero AR, Uchida K, Nakajima H, et al: Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 9: 40, 2012.
26. Chandran AP, Oda K, Shibasaki H and Pisharodi M: Spinal somatosensory evoked potentials in mice and their developmental changes. Brain Dev 16: 44-51, 1994.